Critical Illness Myopathy and GLUT4 Significance of Insulin and Muscle Contraction
Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated. We assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction. In a prospective observat...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 187; no. 4; pp. 387 - 396 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
American Thoracic Society
15.02.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated.
We assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction.
In a prospective observational and interventional pilot study, we screened 874 mechanically ventilated patients with a sepsis-related organ-failure assessment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care unit stay. Thirty patients at risk for CIM underwent euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies. Control subjects were healthy. In five additional patients at risk for CIM, we performed corresponding analyses after 12-day, daily, unilateral electrical muscle stimulation with the contralateral leg as control.
We performed successive muscle biopsies and assessed systemic insulin sensitivity and signal transduction pathways of glucose utilization at the mRNA and protein level and glucose transporter-4 (GLUT4) localization in skeletal muscle tissue. Skeletal muscle GLUT4 was trapped at perinuclear spaces, most pronounced in patients with CIM, but resided at the sarcolemma in control subjects. Glucose metabolism was not stimulated during euglycemic-hyperinsulinergic clamp. Insulin signal transduction was competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK) was not detectable in CIM muscle. Electrical muscle stimulation increased p-AMPK, repositioned GLUT4, locally improved glucose metabolism, and prevented type-2 fiber atrophy.
Insufficient GLUT4 translocation results in decreased glucose supply in patients with CIM. Failed AMPK activation is involved. Evoked muscle contraction may prevent muscle-specific AMPK failure, restore GLUT4 disposition, and diminish protein breakdown. Clinical trial registered with http://www.controlled-trials.com (registration number ISRCTN77569430). |
---|---|
AbstractList | Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated.RATIONALECritical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated.We assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction.OBJECTIVESWe assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction.In a prospective observational and interventional pilot study, we screened 874 mechanically ventilated patients with a sepsis-related organ-failure assessment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care unit stay. Thirty patients at risk for CIM underwent euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies. Control subjects were healthy. In five additional patients at risk for CIM, we performed corresponding analyses after 12-day, daily, unilateral electrical muscle stimulation with the contralateral leg as control.METHODSIn a prospective observational and interventional pilot study, we screened 874 mechanically ventilated patients with a sepsis-related organ-failure assessment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care unit stay. Thirty patients at risk for CIM underwent euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies. Control subjects were healthy. In five additional patients at risk for CIM, we performed corresponding analyses after 12-day, daily, unilateral electrical muscle stimulation with the contralateral leg as control.We performed successive muscle biopsies and assessed systemic insulin sensitivity and signal transduction pathways of glucose utilization at the mRNA and protein level and glucose transporter-4 (GLUT4) localization in skeletal muscle tissue. Skeletal muscle GLUT4 was trapped at perinuclear spaces, most pronounced in patients with CIM, but resided at the sarcolemma in control subjects. Glucose metabolism was not stimulated during euglycemic-hyperinsulinergic clamp. Insulin signal transduction was competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK) was not detectable in CIM muscle. Electrical muscle stimulation increased p-AMPK, repositioned GLUT4, locally improved glucose metabolism, and prevented type-2 fiber atrophy.MEASUREMENTS AND MAIN RESULTSWe performed successive muscle biopsies and assessed systemic insulin sensitivity and signal transduction pathways of glucose utilization at the mRNA and protein level and glucose transporter-4 (GLUT4) localization in skeletal muscle tissue. Skeletal muscle GLUT4 was trapped at perinuclear spaces, most pronounced in patients with CIM, but resided at the sarcolemma in control subjects. Glucose metabolism was not stimulated during euglycemic-hyperinsulinergic clamp. Insulin signal transduction was competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK) was not detectable in CIM muscle. Electrical muscle stimulation increased p-AMPK, repositioned GLUT4, locally improved glucose metabolism, and prevented type-2 fiber atrophy.Insufficient GLUT4 translocation results in decreased glucose supply in patients with CIM. Failed AMPK activation is involved. Evoked muscle contraction may prevent muscle-specific AMPK failure, restore GLUT4 disposition, and diminish protein breakdown. Clinical trial registered with http://www.controlled-trials.com (registration number ISRCTN77569430).CONCLUSIONSInsufficient GLUT4 translocation results in decreased glucose supply in patients with CIM. Failed AMPK activation is involved. Evoked muscle contraction may prevent muscle-specific AMPK failure, restore GLUT4 disposition, and diminish protein breakdown. Clinical trial registered with http://www.controlled-trials.com (registration number ISRCTN77569430). Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated. We assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction. In a prospective observational and interventional pilot study, we screened 874 mechanically ventilated patients with a sepsis-related organ-failure assessment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care unit stay. Thirty patients at risk for CIM underwent euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies. Control subjects were healthy. In five additional patients at risk for CIM, we performed corresponding analyses after 12-day, daily, unilateral electrical muscle stimulation with the contralateral leg as control. We performed successive muscle biopsies and assessed systemic insulin sensitivity and signal transduction pathways of glucose utilization at the mRNA and protein level and glucose transporter-4 (GLUT4) localization in skeletal muscle tissue. Skeletal muscle GLUT4 was trapped at perinuclear spaces, most pronounced in patients with CIM, but resided at the sarcolemma in control subjects. Glucose metabolism was not stimulated during euglycemic-hyperinsulinergic clamp. Insulin signal transduction was competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK) was not detectable in CIM muscle. Electrical muscle stimulation increased p-AMPK, repositioned GLUT4, locally improved glucose metabolism, and prevented type-2 fiber atrophy. Insufficient GLUT4 translocation results in decreased glucose supply in patients with CIM. Failed AMPK activation is involved. Evoked muscle contraction may prevent muscle-specific AMPK failure, restore GLUT4 disposition, and diminish protein breakdown. Clinical trial registered with http://www.controlled-trials.com (registration number ISRCTN77569430). Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated. We assessed signal transduction in skeletal muscle of patients at risk for CIM. We also investigated the effects of evoked muscle contraction. In a prospective observational and interventional pilot study, we screened 874 mechanically ventilated patients with a sepsis-related organ-failure assessment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care unit stay. Thirty patients at risk for CIM underwent euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies. Control subjects were healthy. In five additional patients at risk for CIM, we performed corresponding analyses after 12-day, daily, unilateral electrical muscle stimulation with the contralateral leg as control. We performed successive muscle biopsies and assessed systemic insulin sensitivity and signal transduction pathways of glucose utilization at the mRNA and protein level and glucose transporter-4 (GLUT4) localization in skeletal muscle tissue. Skeletal muscle GLUT4 was trapped at perinuclear spaces, most pronounced in patients with CIM, but resided at the sarcolemma in control subjects. Glucose metabolism was not stimulated during euglycemic-hyperinsulinergic clamp. Insulin signal transduction was competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK) was not detectable in CIM muscle. Electrical muscle stimulation increased p-AMPK, repositioned GLUT4, locally improved glucose metabolism, and prevented type-2 fiber atrophy. Insufficient GLUT4 translocation results in decreased glucose supply in patients with CIM. Failed AMPK activation is involved. Evoked muscle contraction may prevent muscle-specific AMPK failure, restore GLUT4 disposition, and diminish protein breakdown. Clinical trial registered with http://www.controlled-trials.com (registration number ISRCTN77569430). |
Author | Chadt, Alexandra Spies, Claudia D. Faust, Katharina Spranger, Joachim Wollersheim, Tobias Weber-Carstens, Steffen Kleber, Christian Fielitz, Jens Luft, Friedrich C. Boschmann, Michael Wenzel, Katrin Bierbrauer, Jeffrey Al Hasani, Hadi Spuler, Simone Assmann, Anke Marg, Andreas Mai, Knut Schneider, Joanna Koch, Susanne |
Author_xml | – sequence: 1 givenname: Steffen surname: Weber-Carstens fullname: Weber-Carstens, Steffen organization: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum – sequence: 2 givenname: Joanna surname: Schneider fullname: Schneider, Joanna organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 3 givenname: Tobias surname: Wollersheim fullname: Wollersheim, Tobias organization: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum – sequence: 4 givenname: Anke surname: Assmann fullname: Assmann, Anke organization: Department of Endocrinology – sequence: 5 givenname: Jeffrey surname: Bierbrauer fullname: Bierbrauer, Jeffrey organization: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum – sequence: 6 givenname: Andreas surname: Marg fullname: Marg, Andreas organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 7 givenname: Hadi surname: Al Hasani fullname: Al Hasani, Hadi organization: German Diabetes Center, Leibniz-Center for Diabetes Research, University Düsseldorf, Düsseldorf, Germany – sequence: 8 givenname: Alexandra surname: Chadt fullname: Chadt, Alexandra organization: German Diabetes Center, Leibniz-Center for Diabetes Research, University Düsseldorf, Düsseldorf, Germany – sequence: 9 givenname: Katrin surname: Wenzel fullname: Wenzel, Katrin organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 10 givenname: Susanne surname: Koch fullname: Koch, Susanne organization: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum – sequence: 11 givenname: Jens surname: Fielitz fullname: Fielitz, Jens organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 12 givenname: Christian surname: Kleber fullname: Kleber, Christian organization: Department of Traumatology and Reconstructive Surgery, and – sequence: 13 givenname: Katharina surname: Faust fullname: Faust, Katharina organization: Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany – sequence: 14 givenname: Knut surname: Mai fullname: Mai, Knut organization: Department of Endocrinology – sequence: 15 givenname: Claudia D. surname: Spies fullname: Spies, Claudia D. organization: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum – sequence: 16 givenname: Friedrich C. surname: Luft fullname: Luft, Friedrich C. organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 17 givenname: Michael surname: Boschmann fullname: Boschmann, Michael organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and – sequence: 18 givenname: Joachim surname: Spranger fullname: Spranger, Joachim organization: Department of Endocrinology – sequence: 19 givenname: Simone surname: Spuler fullname: Spuler, Simone organization: Experimental and Clinical Research Center, a joint cooperation between the Charité-Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine, Berlin, Germany; and |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27041134$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23239154$$D View this record in MEDLINE/PubMed |
BookMark | eNp90UtLAzEQB_AgFfvQL-BBForgZWsmyT5ylEVrodJLC95CTLK4ZR812T3025tlq0IPnpLAb4aZ_KdoVDe1QegW8AIgZo9WqWpBMBDMQ__mm-wCTSCiUch4gkf-jhMaMsbfx2jq3B57mgK-QmNCCeUQsQmaZ7ZoCyXLYFWWtXEueDs2B9l-HgNZ62C53m3ZNbrMZenMzemcod3L8zZ7Ddeb5Sp7WoeKxtCGNKdMA-OYmAQTLoHyONZa4zQBkyosgeV5TtI8jRjRBoOWRmmGwYM4YZTO0MPQ92Cbr864VlSFU6YsZW2azgk_fco5iyLwdH5G901naz-dAAoRsITivuHdSXUfldHiYItK2qP4Wd-D-xOQzv9BbmWtCvfnEswAaO_I4JRtnLMm_yWARZ-F6LMQQxZiyMIXpWdFqmhlWzR1a2VR_lf6Dcw0ioE |
CitedBy_id | crossref_primary_10_1002_jcsm_12978 crossref_primary_10_1152_physrev_00028_2014 crossref_primary_10_1213_ANE_0000000000004068 crossref_primary_10_1016_j_ijge_2017_01_001 crossref_primary_10_1186_s13613_016_0167_z crossref_primary_10_1007_s00134_024_07532_2 crossref_primary_10_1007_s00115_016_0071_7 crossref_primary_10_1186_s13613_016_0184_y crossref_primary_10_1002_jpen_2481 crossref_primary_10_1016_j_jbiomech_2023_111582 crossref_primary_10_1186_s13054_022_04101_1 crossref_primary_10_1002_jbmr_2884 crossref_primary_10_1186_s13054_016_1576_y crossref_primary_10_1186_s13728_015_0036_7 crossref_primary_10_3389_fphys_2022_865437 crossref_primary_10_3389_fimmu_2022_878755 crossref_primary_10_3390_nu15051071 crossref_primary_10_1007_s00063_014_0375_y crossref_primary_10_1038_s41598_019_43696_4 crossref_primary_10_1186_s13054_014_0545_6 crossref_primary_10_1002_mus_24175 crossref_primary_10_1038_s41598_020_58213_1 crossref_primary_10_1186_s13613_020_0635_3 crossref_primary_10_1002_jcsm_12920 crossref_primary_10_12968_hmed_2020_0045 crossref_primary_10_3390_biom11091327 crossref_primary_10_1007_s00134_015_3979_7 crossref_primary_10_1096_fj_202100711RR crossref_primary_10_1159_000510085 crossref_primary_10_1007_s00134_017_4757_5 crossref_primary_10_1074_jbc_RA118_006790 crossref_primary_10_1164_rccm_201306_1162ED crossref_primary_10_1007_s00424_018_2180_6 crossref_primary_10_1371_journal_pone_0171562 crossref_primary_10_3390_ijms21217840 crossref_primary_10_1016_j_chest_2018_08_1028 crossref_primary_10_1016_j_jcrc_2020_11_018 crossref_primary_10_1186_s40635_023_00503_9 crossref_primary_10_1186_s13054_015_0979_5 crossref_primary_10_1186_s13054_015_1160_x crossref_primary_10_1007_s00101_015_0071_1 crossref_primary_10_1152_ajpendo_00501_2018 crossref_primary_10_1016_j_jcrc_2021_01_012 crossref_primary_10_1186_s13054_018_2030_0 crossref_primary_10_1002_jpen_2190 crossref_primary_10_1038_s41598_021_04517_9 crossref_primary_10_1186_s13063_019_3745_1 crossref_primary_10_1097_MCO_0000000000000165 crossref_primary_10_1111_apha_13962 crossref_primary_10_3390_ijms24032772 crossref_primary_10_1186_s40560_019_0417_x crossref_primary_10_3390_healthcare11050732 crossref_primary_10_1177_0148607116657649 crossref_primary_10_1371_journal_pone_0092048 crossref_primary_10_1590_1809_2950_21003529032022en crossref_primary_10_1007_s00101_022_01166_z crossref_primary_10_1007_s00134_014_3224_9 crossref_primary_10_1038_s41467_023_42659_8 crossref_primary_10_1016_j_neulab_2013_02_002 crossref_primary_10_1002_jcsm_12867 crossref_primary_10_1016_j_jcrc_2017_03_014 crossref_primary_10_1016_j_apmr_2017_10_028 crossref_primary_10_1136_bmj_2023_077292 crossref_primary_10_1016_j_bbrc_2017_02_072 crossref_primary_10_1097_MCO_0000000000000150 crossref_primary_10_3390_ijms23042398 crossref_primary_10_1097_MCO_0000000000000151 crossref_primary_10_1186_2197_425X_3_S1_A520 crossref_primary_10_3390_ijms24065516 crossref_primary_10_1164_rccm_201306_1164WS crossref_primary_10_3166_rea_2018_0068 crossref_primary_10_3389_fendo_2024_1452993 crossref_primary_10_1016_j_clnu_2019_05_027 crossref_primary_10_1097_CCM_0000000000002056 crossref_primary_10_1186_s13613_021_00893_7 crossref_primary_10_1136_thoraxjnl_2016_208844 crossref_primary_10_1186_s13054_015_0993_7 crossref_primary_10_3390_jcm11030846 crossref_primary_10_5847_wjem_j_issn_1920_8642_2013_03_008 crossref_primary_10_1002_jcsm_12620 crossref_primary_10_1136_thoraxjnl_2017_211073 |
Cites_doi | 10.1016/S1474-4422(11)70178-8 10.1212/WNL.46.3.731 10.2337/db08-1775 10.1016/j.clnu.2006.01.021 10.1164/rccm.200605-665OC 10.1097/CCM.0b013e318180b90e 10.1172/JCI29027 10.1038/nature10986 10.1016/j.metabol.2006.08.014 10.1097/CCM.0b013e3181a92f28 10.1016/S0140-6736(09)60658-9 10.1001/jama.288.22.2859 10.4161/cib.3.3.11457 10.1212/WNL.46.3.819 10.1097/01.CCM.0000298158.12101.41 10.1073/pnas.0705070104 10.1038/nrm3311 10.1016/j.molcel.2008.03.003 10.1073/pnas.92.13.5817 10.1073/pnas.1105062108 10.1073/pnas.1106201108 10.1023/A:1006823109415 10.1186/cc9074 10.1097/CCM.0b013e31823295e6 10.1210/jcem.85.10.6914 10.1056/NEJMoa1011802 10.1038/333183a0 10.1021/bi2000356 10.1164/rccm.201107-1320OE 10.1146/annurev.med.49.1.235 10.1128/MCB.21.5.1633-1646.2001 10.1038/78693 10.1056/NEJMoa011300 10.1210/jc.2009-1293 10.2119/2008-00081.Thompson 10.1378/chest.06-2065 10.1097/CCM.0b013e3181a19ceb 10.1097/CCM.0b013e31822d7c18 10.1210/endo-124-1-449 10.2337/db10-0233 10.1046/j.1365-2990.1998.00144.x 10.2337/diabetes.48.8.1667 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS Copyright American Thoracic Society Feb 15, 2013 |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: Copyright American Thoracic Society Feb 15, 2013 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1164/rccm.201209-1649OC |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-4970 |
EndPage | 396 |
ExternalDocumentID | 2910733731 23239154 27041134 10_1164_rccm_201209_1649OC |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 0R~ 23M 2WC 34G 39C 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAWTL AAYXX ABJNI ABOCM ABPMR ABUWG ACGFO ACGFS ADBBV AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 H13 HMCUK HZ~ IH2 J5H KQ8 L7B M1P M5~ NAPCQ O9- OBH OFXIZ OGEVE OK1 OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RWL SJN TAE TEORI THO TR2 UKHRP W8F WH7 WOQ WOW X7M ZXP ~02 .GJ 1CY 1KJ 3O- AAEJM AAQQT ACBNA AFFNX AFUWQ AI. AJJEV IQODW N4W OHT PJZUB PPXIY VH1 YJK ZE2 ZGI CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c361t-3f34d14902e7029a13966ddd0871e8c0a14fff28f8542de01daecd40108767433 |
IEDL.DBID | 7X7 |
ISSN | 1073-449X 1535-4970 |
IngestDate | Fri Jul 11 10:33:13 EDT 2025 Fri Jul 25 02:06:17 EDT 2025 Mon Jul 21 05:40:25 EDT 2025 Mon Jul 21 09:16:09 EDT 2025 Tue Jul 01 00:53:41 EDT 2025 Thu Apr 24 23:13:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Pancreatic hormone Intensive care Critical illness neuromyopathy Muscle contraction Insulin Resuscitation |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c361t-3f34d14902e7029a13966ddd0871e8c0a14fff28f8542de01daecd40108767433 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 23239154 |
PQID | 1315147303 |
PQPubID | 40575 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1288994551 proquest_journals_1315147303 pubmed_primary_23239154 pascalfrancis_primary_27041134 crossref_primary_10_1164_rccm_201209_1649OC crossref_citationtrail_10_1164_rccm_201209_1649OC |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-02-15 |
PublicationDateYYYYMMDD | 2013-02-15 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | American journal of respiratory and critical care medicine |
PublicationTitleAlternate | Am J Respir Crit Care Med |
PublicationYear | 2013 |
Publisher | American Thoracic Society |
Publisher_xml | – name: American Thoracic Society |
References | bib14 bib36 bib15 bib37 bib12 bib34 bib13 bib35 bib10 bib32 bib11 bib33 bib30 bib31 bib29 bib27 bib28 Martin J (bib24) 2010; 8 Winder WW (bib40) 1996; 270 bib25 bib26 bib23 bib21 bib43 bib22 bib44 bib41 bib20 bib42 bib9 bib7 bib8 bib5 bib18 bib6 bib19 bib3 bib16 bib38 bib4 bib17 bib39 bib1 bib2 |
References_xml | – ident: bib9 doi: 10.1016/S1474-4422(11)70178-8 – ident: bib28 doi: 10.1212/WNL.46.3.731 – ident: bib26 doi: 10.2337/db08-1775 – ident: bib25 doi: 10.1016/j.clnu.2006.01.021 – ident: bib14 doi: 10.1164/rccm.200605-665OC – ident: bib10 doi: 10.1097/CCM.0b013e318180b90e – ident: bib21 doi: 10.1172/JCI29027 – ident: bib44 doi: 10.1038/nature10986 – ident: bib34 doi: 10.1016/j.metabol.2006.08.014 – ident: bib4 doi: 10.1097/CCM.0b013e3181a92f28 – ident: bib11 doi: 10.1016/S0140-6736(09)60658-9 – ident: bib2 doi: 10.1001/jama.288.22.2859 – ident: bib17 doi: 10.4161/cib.3.3.11457 – ident: bib7 doi: 10.1212/WNL.46.3.819 – ident: bib23 doi: 10.1097/01.CCM.0000298158.12101.41 – ident: bib29 doi: 10.1073/pnas.0705070104 – ident: bib39 doi: 10.1038/nrm3311 – ident: bib42 doi: 10.1016/j.molcel.2008.03.003 – ident: bib20 doi: 10.1073/pnas.92.13.5817 – ident: bib41 doi: 10.1073/pnas.1105062108 – ident: bib43 doi: 10.1073/pnas.1106201108 – ident: bib36 doi: 10.1023/A:1006823109415 – ident: bib12 doi: 10.1186/cc9074 – ident: bib6 doi: 10.1097/CCM.0b013e31823295e6 – ident: bib33 doi: 10.1210/jcem.85.10.6914 – ident: bib3 doi: 10.1056/NEJMoa1011802 – ident: bib19 doi: 10.1038/333183a0 – volume: 8 year: 2010 ident: bib24 publication-title: Ger Med Sci – ident: bib31 doi: 10.1021/bi2000356 – ident: bib5 doi: 10.1164/rccm.201107-1320OE – ident: bib35 doi: 10.1146/annurev.med.49.1.235 – ident: bib38 doi: 10.1128/MCB.21.5.1633-1646.2001 – ident: bib16 doi: 10.1038/78693 – ident: bib13 doi: 10.1056/NEJMoa011300 – ident: bib27 doi: 10.1210/jc.2009-1293 – ident: bib37 doi: 10.2119/2008-00081.Thompson – ident: bib1 doi: 10.1378/chest.06-2065 – ident: bib32 doi: 10.1097/CCM.0b013e3181a19ceb – volume: 270 start-page: E299 year: 1996 ident: bib40 publication-title: Am J Physiol – ident: bib15 doi: 10.1097/CCM.0b013e31822d7c18 – ident: bib18 doi: 10.1210/endo-124-1-449 – ident: bib30 doi: 10.2337/db10-0233 – ident: bib8 doi: 10.1046/j.1365-2990.1998.00144.x – ident: bib22 doi: 10.2337/diabetes.48.8.1667 |
SSID | ssj0012810 |
Score | 2.402792 |
Snippet | Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated.
We assessed signal... Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated. We assessed signal... Critical illness myopathy (CIM) has no known cause and no treatment. Immobilization and impaired glucose metabolism are implicated.RATIONALECritical illness... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 387 |
SubjectTerms | Adenosine Adult Aged Analgesics Analysis of Variance Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Biopsy Biopsy - methods Critical Illness Digestive system Electric Stimulation - methods Enteral nutrition Female Glucose Glucose Clamp Technique - methods Glucose Transporter Type 4 - genetics Glucose Transporter Type 4 - metabolism Humans Hypoglycemic Agents - metabolism Hypoglycemic Agents - pharmacology Illnesses Insulin - metabolism Insulin - pharmacology Insulin resistance Intensive care Intensive care medicine Investigative techniques, diagnostic techniques (general aspects) Kinases Male Medical sciences Metabolism Microdialysis - methods Middle Aged Morphology Muscle Contraction Muscular Diseases - complications Muscular Diseases - genetics Muscular Diseases - pathology Muscular Diseases - physiopathology Musculoskeletal system Neuromuscular electrical stimulation Organ Dysfunction Scores Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Pilot Projects Prospective Studies Proteins Respiration, Artificial Sepsis - complications Signal Transduction |
Subtitle | Significance of Insulin and Muscle Contraction |
Title | Critical Illness Myopathy and GLUT4 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23239154 https://www.proquest.com/docview/1315147303 https://www.proquest.com/docview/1288994551 |
Volume | 187 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqVQQtNH6jZZVOitiFjS2Cv3Utolr9JNS5OFvRmvHqWw2Nt9HPLvM2PZG3JILr5YGszMWPpGo_mGsU8gg8mMCkLmBQhAhCCMmWUiy1yu9QwK5-lAf3yZn0_gxzSbdgduq-5aZb8mtgu1ayydkR9LjXsToD_qr4v_grpGUXa1a6HxlO0SdRl59XC6DbgoSRTZCIZaABTTvmgmh-OltVSHTpWj-JlQ_Brd25heLKoV6ijE5hYPo892Fzp9yfY6-Mi_RXvvsye-fsWejbsE-Wt21bcu4BfzOa1ifHzTUNfhG17Vjp_9nFzDF371729NV4TI4rwJ_CJeSG-HjDcrlMyJtWoZix7esMnpyfXoXHR9E4TVuVwLHTQ4jHxS5YepKioEeXnunEsxOPLGppWEEIIyaCVQzqfSVd46DLSIng4RhX7Lduqm9u8Yn-VEuBesB4SJwRSVQ0CQZRZ3_QLlFAmTvdJK25GKU2-LedkGFzmUpOgyKrqMik7Y5-2cRaTUeHT04J4ttlPUMAUpNSTssDdO2f1_q_LOWxL2cfsa_xxKh1S1bzY4RhkMNgEhY8IOolHvhGtFzPnw_nHhH9hz1bbHUEJmh2xnvdz4IwQp69mg9UR8mpEcsN3vJ5e__9wC4-Li0g |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7UCiqIeDda6wj6JEMzl2QTQURW667d1Ifuwr7FbGamFJZk3Quyf8rf6DmZZEsf7FvfApk5kHOZ-U7ODeCdFi6JEum4iFPNNSIEniSziEeRiZWa6dRY-qGfncaDif4xjaZ78LerhaG0yu5MbA5qU5f0j_xIKLybNOqj-rz4zWlqFEVXuxEaXi1O7PYPumyrT8OvKN_3Uh5_G_cHvJ0qwEsVizVXTmmDfkEobS-UaYEQKI6NMSG6DjYpw0Jo55xM8Bu0NDYUprClQTeEmrfhfauQ7i24jQ89sqikv0spoaCU737QU1zrdNoV6cT6aFmWVPdOlarIFp3-7F-5CO8vihXKxPlhGv9Hu82td_wQHrRwlX3x-vUI9mz1GO5kbUD-CZx1oxLYcD6nU5Nl25qmHG9ZURn2fTQZ64_s7OK8opQk0jBWOzb0CfDNkmyzQsqMumQtfZHFU5jcCEefwX5VV_YFsFlMDf5caTXCUpekhUEAEkUloowU6aQBiI5pedk2MadZGvO8cWZinROjc8_o3DM6gA-7PQvfwuPa1YdXZLHbInuhFkLpAA464eStva_yS-0M4O3uNVoqhV-KytYbXCMTdG41QtQAnnuhXhJXkjr165fXE38DdwfjbJSPhqcnr-CebEZzSC6iA9hfLzf2NQKk9eyw0UoGv27aDP4B7YMbvQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEF9qhSKI-G201hX0SZZLdifJRhCRq2fP9qrQHtxbzGV3S-FIzvtA7l_zr3Mmm1zpg33rc3YHMh87v9mdD8beQeR0rKUTUZKBAEQIQutpLOLYJEpNITOWLvRHp8nRGL5P4skO-9vVwlBaZXcmNge1qUu6I-9FCn0ToD6qnmvTIn4eDj7PfwuaIEUvrd04Da8ix3bzB8O35afhIcr6vZSDr-f9I9FOGBClSqKVUE6BwRghlDYNZVYgHEoSY0yIYYTVZVhE4JyTGv8HpLFhZApbGgxJqJEb-l6FdO-wu6lKNdmY7m_TS-iByndCSJUAyCZdwU4CvUVZUg08Va0iiyD70b_mFO_PiyXKx_nBGv9Hvo0HHDxkD1royr94XXvEdmz1mO2N2sf5J-ysG5vAh7MZnaB8tKlp4vGGF5Xh307G5_CRn11eVJSeRNrGa8eHPhm-WTJaL5Eyp45ZC19w8ZSNb4Wjz9huVVf2BePThJr9udICQlSns8IgGInjEhFHhnSygEUd0_KybWhOczVmeRPYJJATo3PP6NwzOmAftnvmvp3HjasPrsliu0WmIUSRgoDtd8LJW9tf5leaGrC3289otfQUU1S2XuMaqTHQBYSrAXvuhXpFXEnq2g8vbyb-hu2hAeQnw9PjV-yebKZ0SBHF-2x3tVjb14iVVtODRik5-3XbVvAPS4cf8w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Critical+Illness+Myopathy+and+GLUT4&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Weber-Carstens%2C+Steffen&rft.au=Schneider%2C+Joanna&rft.au=Wollersheim%2C+Tobias&rft.au=Assmann%2C+Anke&rft.date=2013-02-15&rft.issn=1073-449X&rft.eissn=1535-4970&rft.volume=187&rft.issue=4&rft.spage=387&rft.epage=396&rft_id=info:doi/10.1164%2Frccm.201209-1649OC&rft.externalDBID=n%2Fa&rft.externalDocID=10_1164_rccm_201209_1649OC |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |